Redmile Group, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 65 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2019$264,000
+125.6%
22,2360.0%0.01%
+133.3%
Q1 2019$117,000
+67.1%
22,2360.0%0.00%0.0%
Q4 2018$70,000
-48.1%
22,2360.0%0.00%
-25.0%
Q3 2018$135,000
+14.4%
22,2360.0%0.00%0.0%
Q2 2018$118,000
-8.5%
22,2360.0%0.00%
-20.0%
Q1 2018$129,000
+65.4%
22,2360.0%0.01%
+66.7%
Q4 2017$78,000
-3.7%
22,2360.0%0.00%
-25.0%
Q3 2017$81,000
+44.6%
22,2360.0%0.00%
+33.3%
Q2 2017$56,000
-6.7%
22,2360.0%0.00%
-25.0%
Q1 2017$60,000
-6.2%
22,2360.0%0.00%
-33.3%
Q4 2016$64,000
-29.7%
22,2360.0%0.01%
-14.3%
Q3 2016$91,000
+30.0%
22,2360.0%0.01%0.0%
Q2 2016$70,00022,2360.01%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2017
NameSharesValueWeighting ↓
VHCP Management, LLC 1,102,735$3,485,0003.61%
VHCP Management II, LLC 280,000$885,0000.53%
GREAT POINT PARTNERS LLC 550,116$1,738,0000.50%
JW Asset Management, LLC 189,919$600,0000.48%
DAFNA Capital Management LLC 140,600$444,0000.35%
Granite Point Capital Management, L.P. 186,544$589,0000.25%
SABBY MANAGEMENT, LLC 779,926$2,465,0000.13%
TFS CAPITAL LLC 159,364$504,0000.09%
Rhenman & Partners Asset Management AB 154,006$487,0000.09%
Numeric Investors LLC 1,134,931$3,586,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders